StockData
Bioxytran, Inc logo

Bioxytran, Inc (BIXT) stock

BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 20, 2026Score 0/30
$0.02−0.00 (-3.95%)

Close on Oct 19, 2026Market cap $2.57MP/E –Yield –

Bioxytran gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Bioxytran's gross profit for the twelve months ending Jun 30, 2018 was $83.76K, down 25.6% year over year. For fiscal 2017 it was $87.10K, down 42.0% from the year before. The highest annual figure on record is $219.95K in fiscal 2013.

Annual gross profit

PeriodPeriod endValueChange
FY2017Dec 31, 2017$87.10K-42.0%
FY2016Dec 31, 2016$150.19K+25.0%
FY2015Dec 31, 2015$120.14K+9.6%
FY2014Dec 31, 2014$109.64K-50.2%
FY2013Dec 31, 2013$219.95K+15.2%
FY2012Dec 31, 2012$190.98K+233.8%
FY2011Dec 31, 2011$57.22K+373.0%
FY2010Dec 31, 2010$12.10K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2018Jun 30, 2018$12.20K-39.3%
Q1 FY2018Mar 31, 2018-$1.93K–
Q4 FY2017Dec 31, 2017-$6.60K-118.5%
Q3 FY2017Sep 30, 2017$80.09K–
Q2 FY2017Jun 30, 2017$20.08K–
Q1 FY2017Mar 31, 2017-$6.24K–
Q4 FY2016Dec 31, 2016$35.73K–

More Bioxytran figures

See a number that looks wrong?